Insider · CIK 0001757892
Raj Mehra
Files at SEEL (SEELOS THERAPEUTICS, INC.). First filing Dec 1, 2023, latest Dec 1, 2023.
In brief
Raj Mehra files SEC Form 4 as officer and director at SEEL (SEELOS THERAPEUTICS, INC.). Since Dec 1, 2023, Raj Mehra has reported 1 open-market buy worth $100k and 0 open-market sells worth $0, the latest filed on Dec 1, 2023.
A track record needs three past buys with six months of prices behind them; Raj Mehra has 0, so none is measured yet.
The newest scored trade: bought $100k of SEEL on Dec 1, 2023, filed Dec 1, 2023, scored 43 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | SEELOS THERAPEUTICS, INC. | $100k 75,757 shares | +69% | - |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | SEEL SEELOS THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +70,383 | $0.00 | $0 | 70,383 | Jan 17, 2024 |
| Dec 1, 2023 | SEEL SEELOS THERAPEUTICS, INC. | POpen-market purchase Common Stock | +75,757 | $1.32 | $100k | 185,142 | Dec 1, 2023 |
| Dec 1, 2023 | SEEL SEELOS THERAPEUTICS, INC. | POpen-market purchase Common Stock Warrant (right to buy)derivative | +75,757 | - | - | 75,757 | Dec 1, 2023 |
Questions about Raj Mehra
Answered from the filings on this page, as of the latest one.
Is Raj Mehra buying or selling?
Not in the last 12 months. Raj Mehra's latest open-market trade on SEC Form 4 was bought $100k of SEEL on Dec 1, 2023.
How did Raj Mehra's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Raj Mehra has 0.
Where does Raj Mehra file Form 4?
Raj Mehra has filed Form 4 at SEEL (SEELOS THERAPEUTICS, INC.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.